7月31日 - ** 制药商艾伯维ABBV.N股价盘前上涨3.5%至196美元
** 艾伯维将 (link)，年度每股利润从之前预期的11.67美元到11.87美元上调至11.88美元到12.08美元。
** 公司季度每股利润为2.97美元，而分析师平均预期为每股2.88美元--数据由LSEG编制
** 艾伯维第二季度营收为154.2亿美元，预期为150.3亿美元
** Skyrizi第二季度销售额为44.2亿美元，高于预期的40亿美元；Rinvoq销售额为20.3亿美元，高于预期的19.7亿美元。
** 截至上日收盘，股价累计上涨 6.5
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.